SELLAS Life Sciences Group, Inc. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
SELLAS Life Sciences Group, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • SELLAS Life Sciences Group, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.33M, a 21.7% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$32.8M, a 16.3% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. annual Operating Income (Loss) for 2023 was -$37.9M, a 9.73% increase from 2022.
  • SELLAS Life Sciences Group, Inc. annual Operating Income (Loss) for 2022 was -$42M, a 65.9% decline from 2021.
  • SELLAS Life Sciences Group, Inc. annual Operating Income (Loss) for 2021 was -$25.3M, a 48.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.